DermTech, Inc. Gains 47.25%
Tue, Jan 10, 2023 at 06:58 PM
DermTech, Inc. (DMTK:NASDAQ) rocketted at $3.21, representing a gain of 47.2%. On Tue, Jan 10, 2023, DMTK:NASDAQ touched a New 2-Week High of $3.21. The stock got featured on our News Catalysts scanner on Tue, Jan 10, 2023 at 09:11 AM in the 'MISCELLANEOUS' category. From Tue, Dec 27, 2022, the stock recorded 88.89% Up Days and 70.00% Green Days
About DermTech, Inc. (DMTK:NASDAQ)
DermTech Inc is an emerging growth molecular diagnostic company. The company is engaged in marketing and developing novel non-invasive genomic tests to aid in the diagnosis of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. While the company generates revenue through laboratory services.
Top 10 Gainers:
- Biora Therapeutics Inc. (BIOR:NASDAQ), 155.92%
- Party City Holdco Inc. (PRTY:NYSE), 117.91%
- Sotera Health Company (SHC:NASDAQ), 99.65%
- DatChat Inc. (DATS:NASDAQ), 56.46%
- DermTech, Inc. (DMTK:NASDAQ), 47.25%
- Boxed Inc. (BOXD:NYSE), 46.2%
- VYNE Therapeutics Inc. (VYNE:NASDAQ), 45.83%
- Elys Game Technology Corp. (ELYS:NASDAQ), 41.9%
- Ebang International Holdings Inc. (EBON:NASDAQ), 41.48%
- Jianzhi Education Technology Group Company Limited (JZ:NASDAQ), 40.83%